NIKOFRENON 7 mg/24 hours transdermal patch, 7 pcs

Instructions for use for NIKOFRENON 7 mg/24 hours transdermal patch, 7 pcs

Detailed instructions for NIKOFRENON 7 mg/24 hours transdermal patch, 7 pcs

Field of use

nikofrenon® supports the weaning of cigarettes and other tobacco products. It reduces the withdrawal symptoms of nicotine dependency and facilitates the exit from addiction to cigarettes, cigarillos, cigars and other tobacco products.

Well -tolerated gradually, less and less nicotine is being added for 9 - 12 weeks. In this way, physical withdrawal symptoms are significantly reduced.

Advantages of the 24-hour plaster to other forms of application
Guarantees an even active ingredient tax
The uniform output of active ingredients reduces deficiency symptoms and thus the desire for the addictive substance. The habit of regularly adding nicotine (also in the form of chewing gum or spray) is best broken through and relieves the user to think of the addictive substance.
Active ingredient tax over 24 hours
The even availability of the addiction reduces the desire for the 1st cigarette in the morning.

• 24-Hour plaster
• Change once a day in the morning, if possible at the same time
• Change adhesive points (shoulder and upper arms, as well as upper hip) regularly
• Smoking stop before the start of therapy
• Plaster must not be shared
• Roll up with the active ingredient side after use and dispose of the interior of the active ingredient side

Active ingredients / ingredients / ingredients

Nikofrenon 7mg 24 -hour plaster (pack size: 7 pc) contains:

The active ingredient is nicotin.
1 transdermal pavement contains 17.5 mg nicotin (average active ingredient release on the skin 7 mg/24 hours).

The other components are:
Acrylate/vinyl acetate/methacrylate copolymer; medium -chain triglycerides; Basic butyl methacrylate copolymer (Ph. EUR.); Paper; Printed carrier film: poly (ethylenterephthalate), aluminum coated; brown print ink; Protection film: poly (ethylenterephthalate), aluminum coated and siliconized

Contradictions

In the case of known hypersensitivity to one of the above -mentioned ingredients, this product should not be used.

dosage

Recommendation of application of Nikofrenon 7mg 24 -hour plaster (pack size: 7 pc):

Place a plaster on simple and comfortable and comfortable 1 x a day. Nikofrenon® gives off evenly nicotine throughout the day - without unpleasant taste. And you have peace around the clock!

The duration of use is based on the progress of the treatment, after 3-4 weeks the next phase can be started. The therapy should take a total of 9-12 weeks. I.D.R. needs the brain for 3 months to take habits or learn new behavior. The dosage should be reduced after 1 week of continuous application at the earliest.

At the start of treatment with Nikrenon, you have to stop smoking. The nicotine plasters are available in three power strengths: Nikofrenon 7 mg/24 hours, Nikofrenon 14 mg/24 hours and Nikofrenon 21 mg/24 hours.

The start dose depends on its previous smoke habits. For optimal treatment, please depend on the following dosing scheme:

Starting phase 3 - 4 weeks continuation phase 3 - 4 weeks exclusion 3 - 4 weeks more than 20 cigarettes per day Nikofrenon 21 mg/24 hours Nikofrenon 14 mg/24 hours Nikofrenon 7 mg/24 hours
Up to and including 20 cigarettes per day Nikofrenon 14 mg/24 hours Nikofrenon 14 mg/24 hours Nikofrenon 7 mg/24 hours

Taking

• For transdermal application (for sticking onto the skin).
• Glue the transdermal pavement on a healthy, hairless, dry and clean skin area (no lotion, alcohol or ointment remains, etc.), preferably on the upper arm (inside or outside). Other parts of the body to attach are the shoulder area or the upper hip. The transdermal pavement is to be pressed with the palm for 10-20 seconds.
• Glue the transdermal pavement on a healthy, hairless, dry and clean skin area (no lotion, alcohol or ointment remains, etc.), preferably on the upper arm (inside or outside). Other parts of the body to attach are the shoulder area or the upper hip. The transdermal pavement is to be pressed with the palm for 10-20 seconds.
• Under no circumstances should the same skin area be used on consecutive days for sticking the transdermal pavement, i.e. H. A daily change of the skin area must be observed.
• For more information, see use information!
• What should be considered when showering, bathing, sauna or solarium visit?
  • The preparation is not waterproof, but can be left on the skin when showering carefully. From a medical point of view, too, it is not necessary to remove the transdermal pavement from a medical point of view.
    In order to protect the transdermal pavement from moisture, it can be glued over with an ordinary active ingredient -free plaster. Alternatively, there is the possibility of removing a transdermal patch a maximum of 1 - 2 times without affecting its adhesive properties. After removing the skin with the outermost glue edge, it should carefully on a smooth surface, e.g. B. a mirror to be glued on to preserve liability.
  • Under no circumstances should the pavement be left on the skin during a sauna search or a dive. In these cases, uncontrolled nicotine release cannot be excluded.
• What to do if the transdermal patch no longer sticks?
  • If the glue effect of the transdermal pavement has been impaired despite precautionary measures, it can be fixed with an active ingredient -free conventional wound patch.
• Notes for the disposal of used transder painters
  • After removing the transdermal pavement from the skin, keep it together with the adhesive layer in the middle so that the two halves stick together.

Patient information

• Warnings and Precautions
  • Please speak to your doctor or pharmacist before using the preparation at:
    • stable narrowing of the coronary arteries (angina pectoris)
    • older heart attack
    • Varios diseases
    • Circulatory disorders on the arms or legs (e.g. "smoking leg")
    • greatly increased blood pressure
    • Heart muscle weakness
    • Kidney and liver disorders
    • Overfunction of the thyroid gland
    • Epilepsy
    • Muscle weakness (myasthenia gravis, pseudomyasthenic syndrome)
    • Diabetes (diabetes mellitus)
    • Gastric mucosal inflammation and acute stomach and intestinal ulcers
  • In these cases, you should speak to your doctor before using the drug. In this case, the risks of further smoking must be weighed up against the risk of nicotin replacement therapy.
  • In patients with known seizures (i.e. epilepsy), there could be an increased risk of the occurrence of seizures under treatment with the medicine.
  • Patients with well -known muscle weakness (Myasthenia Gravis, pseudomyasthenic syndrome) In the history, under treatment with the preparation, a deterioration of their symptoms caused by muscle weakness can develop.
• Children and adolescents
  • Children must not be treated with this preparation.
    There is no experience in the application of this preparation in patients under the age of 18.
• Older people
  • There are only limited experiences about the use of this medicine in smokers over 65 years, but the effectiveness and tolerance in D seemsto be unproblematic.

 

• Wateriness and ability to operate machines
  • There are no evidence of risks in road traffic or when operating machines as long as the recommended dosage is observed. However, note that behavioral changes can be caused when smoking.

Pregnancy

• If you are pregnant or breastfeed, or if you suspect that you are pregnant or intend to become pregnant, ask your doctor or pharmacist for advice before using this drug.
• Pregnancy
  • Smoking can cause serious damage to the fetus and the baby and should be ended. Pregnant smokers are recommended to smoke smoking without the support of nicotine -containing medicines. The use of this preparation should only be considered after consultation with the doctor if there is a risk of further smoking. In this case, the risks of further smoking (possibly higher nicotinplasmas levels, harmful substances from tobacco smoke) must be weighed up against the risk of nicotine substitution. The risks of the fetus when using the drug are not fully known. The benefits of a smoking cessation supported by nicotine drugs in pregnant smokers who cannot do without smoking without such therapy seems to outweigh the risk associated with continued smoking.
• Breastfeeding
  • Nicotin merges into breast milk. When using the drug in therapeutic doses, nicotine mirrors can be achieved in breast milk that have an effect on the child. If a nicotine substitution with the preparation is required during breastfeeding, the infant must be switched to bottle food.
• Reproductive ability
  • Smoking can have adverse effects on female and male fertility (fertility). It is not known which specific proportion of nicotine has in these effects. If possible, women with desire to have children should neither smoke nor do they do Nicotin replacement therapy.

Hints

nikofrenon 7 mg/24 hours plaster, transdermal pavement; Nikofrenon 14 mg/24 hours plaster, transdermal pavement; Nikofrenon 21 mg/24 hours plaster, transdermal pavement. For use in adults. Active ingredient: Nicotin. Application: Relief of Nicotinentae symptoms, support for smoking cessation in the event of nicotine addiction. Advisory and care for patients usually increase success rates. Stand: 05/2020 On risks and side effects Read the package supplement and ask your doctor or pharmacist.

Manufacturer:  Heumann Pharma GmbH & Co. Generi, Südwestpark 50, 90449 Nuremberg